Ashland expands pharmaceutical plant for Aquarius™ tablet coatings and commissions new microbial protection capability in Brazil, demonstrating strategy to globalize, innovate, and invest
LowReport
Ashland expands pharmaceutical plant for Aquarius™ tablet coatings and commissions new microbial protection capability in Brazil, demonstrating strategy to globalize, innovate, and invest
Ashland Inc. (NYSE: ASH) had its price target lowered by analysts at Wells Fargo & Company from $80.00 to $69.00. They now have an "overweight" rating on the stock.
LowReport
Ashland Inc. (NYSE: ASH) had its price target lowered by analysts at Wells Fargo & Company from $80.00 to $69.00. They now have an "overweight" rating on the stock.
Ashland Inc. (NYSE: ASH) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $71.00 price target on the stock, up previously from $68.00.
LowReport
Ashland Inc. (NYSE: ASH) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $71.00 price target on the stock, up previously from $68.00.
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: